製品名:tert-butyl 5'-bromo-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-carboxylate

IUPAC Name:tert-butyl 5'-bromo-3'H-spiro[azetidine-3,1'-[2]benzofuran]-1-carboxylate

CAS番号:1398609-80-7
分子式:C15H18BrNO3
純度:95%+
カタログ番号:CM104252
分子量:340.22

包装単位 有効在庫 価格(USD) 数量
CM104252-1g in stock Žř
CM104252-5g in stock ǭǭŽ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1398609-80-7
分子式:C15H18BrNO3
融点:-
SMILESコード:CC(C)(C)OC(=O)N1CC2(C1)OCC1=CC(Br)=CC=C21
密度:
カタログ番号:CM104252
分子量:340.22
沸点:
MDL番号:
保管方法:

Category Infos

Azetidines
Azetidines are an important class of saturated four-membered nitrogen-containing heterocyclic compounds. The research hotspots related to this structure mainly focus on two aspects: one is the research of pharmaceutical chemistry; the other is related to chiral azetidines, using rigid azetidine compounds as chiral ligands for asymmetric catalytic reactions. Many nitrogen-containing heterocycles play important roles in drug structures, and in many cases small structural changes can improve ligand selectivity and pharmacokinetic properties.
Where to buy Azetidines
Where to buy ADC-Cytotoxins? Chemenu Provide Azetidines with high quality and competitive price. Contact us Now.

Column Infos

Spiro Compounds
A spiro compound is a polycyclic compound in which two monocyclic rings share one carbon atom; the shared carbon atom is called a spiro atom. Spiro compounds have rigid structures, stable structures, and have special properties that general organic compounds do not possess, such as anomeric effect, spiro conjugation and spiro hyperconjugation. Compared with the monocyclic structure or the planar aromatic structure, the spiro structure has a larger three-dimensional structure; the heterocyclic spiro structure is also regarded as the biological isostere of some groups, which can change the drug to a certain extent. The water solubility, lipophilicity, dominant conformation and ADMET properties of the molecule make the optimized lead molecule easier to drug. Therefore, spiro compounds occupy a very important position in drug development.